{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:05:56Z","timestamp":1767665156950},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s11255-013-0609-6","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T06:50:08Z","timestamp":1385016608000},"page":"941-946","source":"Crossref","is-referenced-by-count":10,"title":["Role of SMAD4 in the mechanism of valproic acid\u2019s inhibitory effect on prostate cancer cell invasiveness"],"prefix":"10.1007","volume":"46","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,22]]},"reference":[{"key":"609_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer Statistics. Ca Cancer J Clin 63:11\u201330","journal-title":"Ca Cancer J Clin"},{"key":"609_CR2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humpath.2010.02.011","volume":"41","author":"M Andreoiu","year":"2010","unstructured":"Andreoiu M, Cheng L (2010) Multifocal prostate cancer: biologic, prognostic and therapeutic implications. Hum Pathol 41:781\u2013793","journal-title":"Hum Pathol"},{"key":"609_CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY et al (2009) Epithelial\u2013mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"609_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R (2009) TGF-\u03b2-induced epithelial to mesenchymal transition. Cell Res 19:156\u2013172","journal-title":"Cell Res"},{"key":"609_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)81132-0","volume":"92","author":"K Takaku","year":"1998","unstructured":"Takaku K, Oshima M, Miyoshi H et al (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645\u2013656","journal-title":"Cell"},{"key":"609_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/pros.20730","volume":"68","author":"AA Aitchison","year":"2008","unstructured":"Aitchison AA, Veerakumarasivam A, Vias M et al (2008) Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer. Prostate 68:661\u2013674","journal-title":"Prostate"},{"key":"609_CR7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature09677","volume":"10","author":"Z Ding","year":"2011","unstructured":"Ding Z, Wu CJ, Chu GC et al (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 10:269\u2013273","journal-title":"Nature"},{"key":"609_CR8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","volume":"20","author":"MH Kuo","year":"1998","unstructured":"Kuo MH, Allis CD (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 20:615\u2013626","journal-title":"BioEssays"},{"key":"609_CR9","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"MA Glozak","year":"2007","unstructured":"Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26:5420\u20135432","journal-title":"Oncogene"},{"key":"609_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10585-007-9131-5","volume":"25","author":"D Mottet","year":"2008","unstructured":"Mottet D, Castronovo V (2008) Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25:183\u2013189","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"609_CR11","first-page":"44","volume":"49","author":"H Zhongxian","year":"2011","unstructured":"Zhongxian H, Xunbo J et al (2011) Effect of valproic acid on autophagy in prostate cancer PC3 cells. J SD 49(7):44\u201347","journal-title":"J SD"},{"key":"609_CR12","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","volume":"66","author":"Q Xia","year":"2006","unstructured":"Xia Q, Sung J, Chowdhury W et al (2006) Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res 66:7237\u20137244","journal-title":"Cancer Res"},{"key":"609_CR13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-2042.2007.01823.x","volume":"14","author":"D Gao","year":"2007","unstructured":"Gao D, Xia Q, Lv J et al (2007) Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo. Int J Urol 14:838\u2013845","journal-title":"Int J Urol"},{"key":"609_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-5-71","volume":"5","author":"J Chen","year":"2006","unstructured":"Chen J, Ghazawi FM, Bakkar W et al (2006) Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt\/protein kinase B. Mol Cancer 5:71\u201381","journal-title":"Mol Cancer"},{"key":"609_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R (2005) Specificity and versatility in TGF-b signaling through Smads. Ann Rev Cell Dev Biol 21:659\u2013693","journal-title":"Ann Rev Cell Dev Biol"},{"key":"609_CR16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.onc.1201232","volume":"15","author":"D MacGrogan","year":"1997","unstructured":"MacGrogan D, Pegram M, Slamon D et al (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15:1111\u20131114","journal-title":"Oncogene"},{"key":"609_CR17","first-page":"2527","volume":"56","author":"M Schutte","year":"1996","unstructured":"Schutte M, Hruban RH, Hedrick L et al (1996) DPC4 gene in various tumor types. Cancer Res 56:2527\u20132530","journal-title":"Cancer Res"},{"key":"609_CR18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/1471-2407-10-599","volume":"10","author":"IP Gorlov","year":"2010","unstructured":"Gorlov IP, Sircar K, Zhao H et al (2010) Prioritizing genes associated with prostate cancer development. BMC Cancer 10:599\u2013606","journal-title":"BMC Cancer"},{"key":"609_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature09677","volume":"10","author":"Z Ding","year":"2011","unstructured":"Ding Z, Wu CJ, Chu GC et al (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 10:269\u2013273","journal-title":"Nature"},{"key":"609_CR20","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/cncr.26285","volume":"117","author":"C Printz","year":"2011","unstructured":"Printz C (2011) Molecular predicator of metastatic cancer identified. Cancer 117:2827\u20132829","journal-title":"Cancer"},{"key":"609_CR21","first-page":"1759","volume":"38","author":"CJ Kim","year":"2011","unstructured":"Kim CJ, Sakamoto K, Tambe Y et al (2011) Opposite regulation of epithelial-to- mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int J Oncol 38:1759\u20131766","journal-title":"Int J Oncol"},{"key":"609_CR22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/carcin\/bgs022","volume":"33","author":"K Lu","year":"2012","unstructured":"Lu K, Georg S, Huajie B et al (2012) Lamin A\/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3\u00a0K\/AKT\/PTEN pathway. Carcinogenesis 33:751\u2013759","journal-title":"Carcinogenesis"},{"key":"609_CR23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","volume":"98","author":"W Weichert","year":"2008","unstructured":"Weichert W, R\u00f6ske A, Gekeler V, Beckers T, Stephan C, Jung K et al (2008) Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer 98:604\u2013610","journal-title":"Br J Cancer"},{"key":"609_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","volume":"59","author":"K Halkidou","year":"2004","unstructured":"Halkidou K, Gaughan L, Cook S et al (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59:177\u2013189","journal-title":"Prostate"},{"key":"609_CR25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbrc.2010.12.081","volume":"404","author":"NH Kim","year":"2011","unstructured":"Kim NH, Kim SN, Kim YK (2011) Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion. Biochem Biophys Res Commun 404:915\u2013921","journal-title":"Biochem Biophys Res Commun"},{"key":"609_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00280-010-1289-x","volume":"66","author":"D Rathkopf","year":"2010","unstructured":"Rathkopf D, Wong BY, Ross RW et al (2010) A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer. Cancer Chemother Pharmacol 66:181\u2013189","journal-title":"Cancer Chemother Pharmacol"},{"key":"609_CR27","first-page":"614","volume":"66","author":"L Zhang","year":"2011","unstructured":"Zhang L, Wang G, Wang L et al (2011) Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression. Pharmazie 66:614\u2013618","journal-title":"Pharmazie"},{"key":"609_CR28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00280-010-1289-x","volume":"66","author":"D Rathkopf","year":"2010","unstructured":"Rathkopf D, Wong BY, Ross RW et al (2010) A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer. Cancer Chemother Pharmacol 66:181\u2013189","journal-title":"Cancer Chemother Pharmacol"},{"key":"609_CR29","doi-asserted-by":"crossref","first-page":"e27178","DOI":"10.1371\/journal.pone.0027178","volume":"6","author":"L Ellis","year":"2011","unstructured":"Ellis L, Lehet K, Ramakrishnan S et al (2011) Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression. PLoS One 6:e27178","journal-title":"PLoS One"},{"key":"609_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-11-375","volume":"11","author":"S Wedel","year":"2011","unstructured":"Wedel S, Hudak L, Seibel JM et al (2011) Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis. BMC Cancer 11:375\u2013389","journal-title":"BMC Cancer"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0609-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-013-0609-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0609-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T18:06:30Z","timestamp":1564855590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-013-0609-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,22]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s11255-013-0609-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,22]]}}}